OCT 02, 2019 3:32 PM PDT

Non-Invasive Gene Therapy Holds Promise for Treating Blindness

WRITTEN BY: Annie Lennon

Researchers at John Hopkins Medicine have found a way to deliver sight-saving gene therapy to the retina. Having already shown success in treating rates, pigs and monkeys with inherited retinal degeneration, should this treatment can also be effective in humans, it may be able to become a more permanent therapeutic option for patients with common diseases such as age-related macular degeneration. 

Currently, gene therapy approaches for inherited eye disorders carry a high risk for patients. For example, the current gene therapy approach for treating Leber congenital amaurosis, an inherited eye disorder, involves a surgical procedure that detaches the retina to inject the gene-carrying virus underneath it. Beyond a risk of retinal detachment, this procedure carries a high risk of patients developing cataracts alongside other vision-threatening complications (John Hopkins Medicine: 2019). 

This is where the new gene therapy approach differs. Unlike other treatments, it is minimally invasive. Rather than involving a surgical procedure, this approach uses a small needle to inject  harmless, genetically engineered viruses into the eye’s suprachoroidal space, the space between the white of the eye and the eye’s muscular layer. From there, the virus may then spread throughout the eye to deliver its therapeutic effects (Ding: 2019). 

Due to its lack of invasiveness, the researchers recognise that this treatment may be used on an outpatient basis, making it more accessible than previous methods for gene therapy. According to Peter Campochiaro, a Professor of Ophthalmology and Neuroscience at the John Hopkins University School of Medicine, "The best time for patients with inherited retinal degeneration to receive gene therapy treatments is when they still have fairly good vision. However, at that time, they also have more to lose from complications. The ability to offer a safer, more convenient procedure would be a breakthrough (John Hopkins Medicine: 2019)." 

Although this gene therapy shows promise, the researchers nevertheless noted that further research, as well as human trials, are needed to secure its efficacy before it can be available to the public. Despite this however, they hope that suprachoroidal injections in this way may soon prove to be a viable treatment option for large numbers of patients with wet age-related macular degeneration as well as other common inherited disorders. 

 

Sources

 

Ding, Kun: JCI

John Hopkins Medicine

 

About the Author
  • Science writer with a keen interest in behavioral biology, consciousness medicine and technology. Her current focus is how the interplay of these fields can create meaningful interactions, products and environments.
You May Also Like
APR 27, 2021
Genetics & Genomics
A Genetic Path Forward For Endangered Sumatran Rhinos
APR 27, 2021
A Genetic Path Forward For Endangered Sumatran Rhinos
There are fewer than 100 Sumatran rhinoceroses remaining in the world, making this animal one of the world's most endang ...
MAY 02, 2021
Genetics & Genomics
Generating Error-Free, Complete Reference Genomes for Vertebrates
MAY 02, 2021
Generating Error-Free, Complete Reference Genomes for Vertebrates
Researchers have generated much more accurate reference materials for genomic studies. The work removed errors and impro ...
MAY 13, 2021
Genetics & Genomics
The Unique Caecilians of São Tomé Island
MAY 13, 2021
The Unique Caecilians of São Tomé Island
There are many islands that have unique flora and fauna, like these limbless creatures (Photo © Andrew Stanbridge) of Sã ...
JUN 15, 2021
Genetics & Genomics
DNA May Soon Become a Digital Storage Device
JUN 15, 2021
DNA May Soon Become a Digital Storage Device
We live in an age of information and data, and more is being generated every day. It's estimated that there are about te ...
JUN 26, 2021
Space & Astronomy
Cardiac Atrophy Findings May Aid Astronauts in Long Space Flights
JUN 26, 2021
Cardiac Atrophy Findings May Aid Astronauts in Long Space Flights
Researchers led by Cincinnati Children’s Hospital Medical Center have discovered the molecular process behind a da ...
JUL 26, 2021
Genetics & Genomics
A Region of Non-Coding DNA That May Help Regulate Telomere Length is ID'ed
JUL 26, 2021
A Region of Non-Coding DNA That May Help Regulate Telomere Length is ID'ed
Many types of cells have to be replenished continuously throughout our lives, and the genome in the nucleus of those cel ...
Loading Comments...